{"id":"W4253674318","doi":"10.1200/jco.2013.31.4_suppl.280","title":"Phase I trial of sorafenib in high-risk hepatocellular carcinoma (HCC) patients after liver transplantation.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Hepatocellular carcinoma; Sorafenib; Internal medicine; Neutropenia; Liver transplantation; Milan criteria; Gastroenterology; Transplantation; Surgery; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001436744,0.001505162,0.00121996,0.0002661133,0.0004126427,0.000843729,0.0006100101,0.001067238,0.005204816],"category_scores_gemma":[0.0006172768,0.0004202969,0.0009100817,0.0002532819,0.0005972878,0.0005831801,0.000336569,0.002017415,0.001142593],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006793396,"about_ca_system_score_gemma":0.001420228,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005127442,"about_ca_topic_score_gemma":0.001282913,"domain_scores_codex":[0.999702,0.000148588,0.00001468988,0.00003841966,0.00002032498,0.00007585672],"domain_scores_gemma":[0.999487,0.00006979486,0.00009104867,0.0000275123,0.00003181515,0.0002927534],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.772009,0.05156409,0.007846653,0.001490988,0.0009741787,0.0004981299,0.0002442129,0.002882894,0.02773075,0.0004896979,0.01158812,0.1226813],"study_design_scores_gemma":[0.773508,0.2125922,0.007181979,0.00004473562,0.0001964277,0.0002621076,0.0000379567,0.001105134,0.00219827,0.0002467586,0.002608537,0.00001792322],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9854012,0.003018919,0.0009160405,0.001169113,0.0003040226,0.004406156,0.00141265,0.0001852191,0.003186708],"genre_scores_gemma":[0.9838284,0.001558769,0.00174428,0.001595345,0.0002584028,0.004215784,0.00277226,0.00003043854,0.003996364],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005204816,"threshold_uncertainty_score":0.01741189,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1039151462997828,"score_gpt":0.3655726797202157,"score_spread":0.2616575334204329,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}